Why is Remus Pharma. falling/rising?

As of 15-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 820.00, which reflects a decrease of 0.55 or 0.07%. The stock has recently hit a new 52-week low of Rs. 813, indicating a significant downward trend. Performance metrics show that the stock has underperformed compared to the Sensex, with a 1-week return of -1.68% and a 1-month return of -7.21%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish sentiment. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 17.27% against the 5-day average, which may indicate waning interest among investors.
In the broader market context, while the Sensex has gained 1.20% over the past week and 1.78% over the past month, Remus Pharmaceuticals has struggled significantly, with a year-to-date decline of 34.33% compared to the benchmark's increase of 6.02%. This stark contrast highlights the stock's underperformance relative to the market. The liquidity of the stock remains adequate for trading, but the overall negative sentiment and declining investor engagement suggest that the stock's price is likely to continue facing downward pressure in the near term.